Immunotherapy of Solid Tumors and New Ideas of Anti-tumor Metastasis
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (20 November 2024) | Viewed by 2308
Special Issue Editor
Interests: cancer immuotherapy; biomarker; immune modulation and reconstitution
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Immunotherapy has created new treatment ideas for the treatment of many cancers, and the quality of life of patients has also been greatly improved. Although immunotherapy has made exciting progress in the treatment of many cancers, such as the use of CAR-T cell therapy to treat tumors, the success of cancer immunotherapy in solid tumors has been limited. In order to challenge the difficulties caused by the immunosuppressive microenvironment that suppresses immune responses, inefficient transport, and heterogeneity of tumor antigens, novel methods have been developed. Research and clinical experience need to be unlocked.
This Special Issue welcomes the submission of comprehensive research article or reviews.
Dr. Antonia Busse
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunotherapy
- solid tumors
- checkpoint molecules
- immunomodulation
- combination therapy
- cell therapy
- biomarkers
- tumor antigens
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
